Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
Primary Industries
- Drugs
- Therapeutic
- Biotechnology
- Disease
- DNA
- Antibody
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1616
Product manufacture, use or sale of vectors or virions solely for use in the genetic alteration of mammalian cells taken from a donor, which cells are to be reintroduced into such donor or introduced into a single, pre-identified human host. Additional property includes the manufacture, use or sale of vectors, virions or cells transformed or transfected with vectors or virions, or the progeny of such cells, which vectors, virions or cells are intended solely for direct administration into a human for therapeutic or diagnostic purposes only by the ultimate user of such product.
Licensed Field shall mean the manufacture, use or sale of vectors, virions or cells transformed or transfected with vectors or virions, or the progeny of such cells, which vectors, virions or cells are intended solely for direct administration into a human for therapeutic or diagnostic purposes only by the ultimate user of such product.
IPSCIO Record ID: 240466
– a non-exclusive world-wide license to exploit the Winter Patent commercially in any way whatsoever by the use of the Reshaping Process in the Fields and by the commercial exploitation in the Fields of any resulting antibodies provided always that any such exploitation does not involve the antibodies detailed.
– a non-exclusive sub-license under the Boss Patents to the extent required to enable the licensee to use the Reshaping Process to produce Products from mammalian cells and for no other purpose.
The Reshaping Process shall mean the genetic engineering of monoclonal antibodies comprising the replacement in whole or in part of the complementarity determining regions of one antibody by those of another as described in the Winter Patent.
The Products shall mean end products produced either directly or indirectly from antibodies which have been modified using the Reshaping Process and which are in a form capable of being marketed or sold upon a commercial basis.
Winter patents relate to Recombinant DNA products and Methods.
Boss patents relate to Multichain Polypeptides or Proteins and Processes for their Production Expression of multichain proteins, such as antibodies, in single hose cells.
IPSCIO Record ID: 294014
Adeno-associated viruses are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which in turn belongs to the family Parvoviridae.
Cystic fibrosis is a hereditary disease that affects the lungs and digestive system. The body produces thick and sticky mucus that can clog the lungs and obstruct the pancreas. Cystic fibrosis (CF) can be life-threatening, and people with the condition tend to have a shorter-than-normal life span.
